目录肽产品
AMYD-005B
Fam-β-Amyloid (1-42)
5Fam-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala
5Fam-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala
Size：0.5
P1(RMB)：2421
MW：4872.5
One letter sequence：6Fam-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA
Molecular Formula：C224H321N55O66S1
Description：42-residue peptide believed to be the major subunit of the vascular and plaque filaments in individuals with Alzheimer's disease, elderly people and patients with Trisomy 21 (Down's Syndrome). Inactive control.
Literature Reference：Neurobiology of Aging, 13, No.5 (1992)
Cas：
P1(RMB)：2421
MW：4872.5
One letter sequence：6Fam-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA
Molecular Formula：C224H321N55O66S1
Description：42-residue peptide believed to be the major subunit of the vascular and plaque filaments in individuals with Alzheimer's disease, elderly people and patients with Trisomy 21 (Down's Syndrome). Inactive control.
Literature Reference：Neurobiology of Aging, 13, No.5 (1992)
Cas：
